These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2505615)

  • 1. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature.
    Balinsky W; Nesbitt S
    Am J Med; 1989 Sep; 87(3):301-5. PubMed ID: 2505615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Costs and benefits.
    Milkovich G
    Hosp Pract (Off Ed); 1993 Jun; 28 Suppl 1():39-43. PubMed ID: 8505397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of home intravenous services.
    Thickson ND
    Pharmacoeconomics; 1993 Mar; 3(3):220-7. PubMed ID: 10146945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness issues for home i.v. therapy in the United States.
    Allen R
    Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the Medicare Catastrophic Coverage Act of 1988 and its impact on health-care delivery.
    Grealy MR
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S4-9. PubMed ID: 2672805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of outpatient parenteral antibiotic therapy in a health maintenance organization.
    Grizzard MB; Harris G; Karns H
    Rev Infect Dis; 1991; 13 Suppl 2():S174-9. PubMed ID: 2017648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies.
    New PB; Swanson GF; Bulich RG; Taplin GC
    Am J Med; 1991 Nov; 91(5):455-61. PubMed ID: 1951407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues.
    Craven PC
    Hosp Formul; 1993 Jan; 28 Suppl 1():41-5. PubMed ID: 10123838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Reimbursement.
    Tierce JC
    Hosp Pract (Off Ed); 1993 Jun; 28 Suppl 1():44-51. PubMed ID: 8505398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of a home intravenous antibiotic program.
    Chamberlain TM; Lehman ME; Groh MJ; Munroe WP; Reinders TP
    Am J Hosp Pharm; 1988 Nov; 45(11):2341-5. PubMed ID: 3228090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost perspectives for outpatient intravenous antimicrobial therapy.
    Tice AD; Hoaglund PA; Nolet B; McKinnon PS; Mozaffari E
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):63S-70S. PubMed ID: 11837549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers.
    Marren J; Rodgers B; Dishon M
    Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review.
    Bryant PA; Katz NT
    Lancet Infect Dis; 2018 Feb; 18(2):e45-e54. PubMed ID: 28822781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct medical cost of managing deep vein thrombosis according to the occurrence of complications.
    O'Brien JA; Caro JJ
    Pharmacoeconomics; 2002; 20(9):603-15. PubMed ID: 12141888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.
    Williams DN; Bosch D; Boots J; Schneider J
    Clin Ther; 1993; 15(1):169-79; discussion 168. PubMed ID: 8458046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home intravenous antibiotic therapy.
    Poretz DM
    Clin Geriatr Med; 1991 Nov; 7(4):749-63. PubMed ID: 1760792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social work in a home intravenous antibiotic therapy program.
    Sharp JW
    Soc Work Health Care; 1986; 12(1):93-101. PubMed ID: 3603328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.